skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Relevant products

Marketing services

Awareness

Key benefits:

  • Direct access to your target Pharma audience
  • Multi or single channel campaigns
  • Effective reporting
pdp image

Lead generation

Key benefits:

  • Direct access to your target Pharma audience
  • Multi or single channel campaigns
  • Measurable results
pdp image

Network in person

Key benefits:

  • Unrivalled brand exposure
  • Talk face to face with your target audience
  • Highly engaged decision makers

Pharma Intelligence latest insights

  • Awareness

    Acute Myeloid Leukemia Market Outlook Seminar

    By Dominique Fontanilla 19 Jun 2018

    There has been little change to standard treatment for AML in recent years; however, 2017 saw a flurry of new targeted drug approvals, sparking significant market growth. Patient age remains the biggest factor in driving treatment decisions for AML. Cases of AML are expected to increase, and prognosis remains poor – especially among older adults. Drug developers are targeting patient segments with high unmet clinical need to gain access to the AML market and the budget impact of AML is expected to grow considerably.

    Topic Cancer

  • Awareness

    Trends in Gene Therapy Seminar

    By Patricia Reilly 19 Jun 2018

    The promises of gene therapy are taking a long time to be fulfilled, in part due to challenges in developing gene vectors capable of safe and efficient delivery of therapeutic genes (transgenes) into patients’ cells. Nonetheless, these challenges are being addressed in innovative ways. A variety of first-generation vectors, both viral and non-viral, have been employed in clinical trials with varying degrees of success, and the experience gained is guiding the design of next-generation vectors.